Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Urology
Fingerprint
Dive into the research topics where John Sfakianos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A rare case of metachronous pituitary germinoma and testicular seminoma: The role of tumor markers in diagnosis and the influence of glucocorticoids on disease progression
Sheskier, R., Verma, P., Kirschenbaum, A., Orelowitz, B., Umphlett, M., Sharif, U., Sfakianos, J., Schlachter, L., Bederson, J. & Levine, A. C., Jun 2025, In: Journal of Clinical and Translational Endocrinology: Case Reports. 36, 100182.Research output: Contribution to journal › Article › peer-review
-
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
Sfakianos, J. P., Basu, A., Laliotis, G., Cumarasamy, S., Rich, J. M., Kommalapati, A., Glover, M., Mahmood, T., Tillu, N., Hoimes, C. J., Selig, G., Kollipara, R., Stewart, T. F., Rivero-Hinojosa, S., Dutta, P., Calhoun, M., Sharma, S., Malhotra, M., ElNaggar, A. C. & Liu, M. C. & 7 others, , 1 Apr 2025, In: European urology oncology. 8, 2, p. 306-314 9 p.Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
Bladder neck involvement in non-muscle-invasive bladder cancer: risk implications and outcomes of BCG vs gemcitabine/docetaxel
Eraky, A., Ben-David, R., Hug, B., Kolanukuduru, K. P., Tillu, N., Wiklund, P., Mehrazin, R. & Sfakianos, J. P., 2025, (Accepted/In press) In: BJU International.Research output: Contribution to journal › Article › peer-review
-
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Figiel, S., Bates, A., Braun, D. A., Eapen, R., Eckstein, M., Manley, B. J., Milowsky, M. I., Mitchell, T. J., Bryant, R. J., Sfakianos, J. P. & Lamb, A. D., Jan 2025, In: European Urology. 87, 1, p. 8-14 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access7 Scopus citations -
Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non–muscle-invasive Bladder Cancer
Kolanukuduru, K. P., Ben-David, R., Lidagoster, S., Almoflihi, M., Tillu, N., Eraky, A., Alerasool, P., Waigankar, N., Attalla, K., Mehrazin, R., Wiklund, P. & Sfakianos, J. P., Jan 2025, In: European Urology Focus. 11, 1, p. 142-149 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Press/Media
-
New Bladder Cancer Findings Reported from Department of Urology (Efficacy of Bacillus Calmette-guerin Compared To Sequential Gemcitabine and Docetaxel In Ta High-grade Non-muscle Invasive Bladder Cancer)
Mehrazin,, R., Wiklund, P., Attalla, K., Waingankar, N. & Sfakianos, J.
27/05/25
1 item of Media coverage
Press/Media
-
Findings on Disease-Free Survival Discussed by Investigators at Icahn School of Medicine at Mount Sinai (Association of Tumor-informed Circulating Tumor Dna Detectability Before and After Radical Cystectomy With Disease-free Survival In ...)
Mehrazin,, R., Sfakianos, J., Wiklund, P., Diniz, M. A. & Galsky, M.
28/04/25
1 item of Media coverage
Press/Media
-
End-of-Quarter Synopsis Monthly : Tilray Brands (TLRY: $1.33) falls a second month, trailing 72% of stocks
Sfakianos, J. & Kaplan,, S.
31/12/24
1 item of Media coverage
Press/Media
-
Investigators from Icahn School of Medicine at Mount Sinai Target Squamous Cell Carcinoma (Squamous Cell Carcinoma of the Upper Urinary Tract: Clinical Characteristics, Treatment Patterns, and Survival Outcomes In the National Cancer Database)
Mehrazin,, R., Badani, K., Tomer, N. & Sfakianos, J.
19/12/24
1 item of Media coverage
Press/Media